GMED - CIK 0001237831
The table below shows GLOBUS MEDICAL INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $202.36M | $177.30M | $52.39M | $53.31M | $44.69M | $63.57M |
| Capital expenditure | $39.62M | $36.10M | $28.57M | $15.99M | $19.97M | $13.67M |
| Investing cash flow | -$182.67M | $131.38M | -$46.58M | $10.99M | -$13.89M | -$125.11M |
| Dividends paid | - | - | - | - | - |
GLOBUS MEDICAL INC reported operating cash flow of $753.45M for fiscal year 2025. That is up 44.7% from $520.64M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $147.82M (FY 2016) to $753.45M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $0.00 | $190.45M | $83.32M | - | - | - |
| Financing cash flow | $18.20M | -$635.40M | -$115.72M | $2.94M | $6.05M | $7.56M |